@article{WuenschRiesHeinzelmannetal.2023,
  author    = {W{\"u}nsch, Anna Chiara and Ries, Elena and Heinzelmann, Sina and Frabschka, Andrea and Wagner, Peter Christoph and Rauch, Theresa and Koderer, Corinna and El-Mesery, Mohamed and Volland, Julian Manuel and K{\"u}bler, Alexander Christian and Hartmann, Stefan and Seher, Axel},
  title     = {Metabolic silencing via methionine-based amino acid restriction in head and neck cancer},
  series = {Current Issues in Molecular Biology},
  volume    = {45},
  journal   = {Current Issues in Molecular Biology},
  number    = {6},
  issn      = {1467-3045},
  doi       = {10.3390/cimb45060289},
  url       = {http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-319257},
  pages     = {4557 -- 4573},
  year      = {2023},
  abstract  = {In recent years, various forms of caloric restriction (CR) and amino acid or protein restriction (AAR or PR) have shown not only success in preventing age-associated diseases, such as type II diabetes and cardiovascular diseases, but also potential for cancer therapy. These strategies not only reprogram metabolism to low-energy metabolism (LEM), which is disadvantageous for neoplastic cells, but also significantly inhibit proliferation. Head and neck squamous cell carcinoma (HNSCC) is one of the most common tumour types, with over 600,000 new cases diagnosed annually worldwide. With a 5-year survival rate of approximately 55\%, the poor prognosis has not improved despite extensive research and new adjuvant therapies. Therefore, for the first time, we analysed the potential of methionine restriction (MetR) in selected HNSCC cell lines. We investigated the influence of MetR on cell proliferation and vitality, the compensation for MetR by homocysteine, the gene regulation of different amino acid transporters, and the influence of cisplatin on cell proliferation in different HNSCC cell lines.},
  language  = {en}
}